Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion
NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

Nutex Health logo
$118.91 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$118.68 -0.22 (-0.19%)
As of 05/22/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Nutex Health Stock (NASDAQ:NUTX)

Advanced

Key Stats

Today's Range
$117.00
$122.36
50-Day Range
$87.01
$136.66
52-Week Range
$77.21
$193.07
Volume
91,390 shs
Average Volume
164,740 shs
Market Capitalization
$818.10 million
P/E Ratio
9.19
Dividend Yield
N/A
Price Target
$205.00
Consensus Rating
Moderate Buy

Company Overview

Nutex Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

NUTX MarketRank™: 

Nutex Health scored higher than 54% of companies evaluated by MarketBeat, and ranked 458th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutex Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

  • Upside Potential

    Nutex Health has a consensus price target of $205.00, representing about 72.4% upside from its current price of $118.91.

  • Amount of Analyst Coverage

    Nutex Health has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nutex Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutex Health is 9.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.78.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutex Health is 9.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.26.

  • Price to Book Value per Share Ratio

    Nutex Health has a P/B Ratio of 1.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nutex Health's valuation and earnings.
  • Percentage of Shares Shorted

    26.18% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 5.29.
  • Change versus previous month

    Short interest in Nutex Health has recently increased by 4.17%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Nutex Health does not currently pay a dividend.

  • Dividend Growth

    Nutex Health does not have a long track record of dividend growth.

  • Search Interest

    Only 2 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Cluster Insider Buying

    4 insiders have purchased shares of Nutex Health in the last three months. Multiple insiders buying is a strong bullish signal.

  • Net Insider Buying

    Over the last three months, insiders have purchased a net $45,705.00 in company stock, which represents 0.0056% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Nutex Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $45,705.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    44.68% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    5.32% of the stock of Nutex Health is held by institutions.

  • Read more about Nutex Health's insider trading history.
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NUTX Stock News Headlines

Nutex Health Inc
Nutex Health NUTX Q2 2025 Earnings Transcript
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel
Nutex Health NUTX Q1 2025 Earnings Transcript
Nutex (NUTX) Q1 2026 Earnings Call Transcript
See More Headlines

NUTX Stock Analysis - Frequently Asked Questions

Nutex Health's stock was trading at $164.62 on January 1st, 2026. Since then, NUTX stock has decreased by 27.8% and is now trading at $118.91.

Nutex Health Inc. (NASDAQ:NUTX) released its quarterly earnings data on Thursday, April, 30th. The company reported $6.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.99 by $2.53. The business earned $216.49 million during the quarter, compared to analysts' expectations of $227.80 million. Nutex Health had a net margin of 10.95% and a trailing twelve-month return on equity of 23.50%.
Read the conference call transcript
.

Nutex Health's stock reverse split on Wednesday, July 3rd 2024.The 1-10 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Top institutional investors of Nutex Health include Empowered Funds LLC (0.47%), SG Americas Securities LLC (0.44%), Segall Bryant & Hamill LLC (0.33%) and Bank of New York Mellon Corp (0.31%). Insiders that own company stock include Thomas T Vo, Kelvin Spears, Warren Hosseinion, Jon Christian Bates, Joshua Detillio, Pamela W Montgomery, Frank E Jaumot and Michael Lee Reed.
View institutional ownership trends
.

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutex Health investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Cricut (CRCT).

Company Calendar

Last Earnings
4/30/2026
Today
5/24/2026
Next Earnings (Estimated)
7/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:NUTX
CIK
1479681
Employees
1,150
Year Founded
N/A

Price Target and Rating

High Price Target
$205.00
Low Price Target
$205.00
Potential Upside/Downside
+72.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$12.94
Trailing P/E Ratio
9.19
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$70.79 million
Net Margins
10.95%
Pretax Margin
28.42%
Return on Equity
23.50%
Return on Assets
10.47%

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
3.14
Quick Ratio
3.12

Sales & Book Value

Annual Sales
$875.26 million
Price / Sales
0.93
Cash Flow
$12.91 per share
Price / Cash Flow
9.21
Book Value
$64.24 per share
Price / Book
1.85

Miscellaneous

Outstanding Shares
6,880,000
Free Float
3,807,000
Market Cap
$818.10 million
Optionable
Not Optionable
Beta
0.25
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:NUTX) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners